<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00627809</url>
  </required_header>
  <id_info>
    <org_study_id>2007-337</org_study_id>
    <nct_id>NCT00627809</nct_id>
  </id_info>
  <brief_title>Effect of Adjunctive Intracoronary Streptokinase on Late Term Left Ventricular Infarct Size and Volumes in Patients With Acute Myocardial Infarction</brief_title>
  <official_title>Phase 4 Study of Application of Intracoronary Low Dose Streptokinase Complementary to Standard Percutaneous Coronary Intervention in Patients With ST Elevation Acute Myocardial Infarction: Effect of Adjunctive Intracoronary Streptokinase on Late Term Left Ventricular Infarct Size and Volumes in Patients With Acute Myocardial Infarction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istanbul University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istanbul University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesized that complementary intracoronary streptokinase administration
      to primary percutaneous intervention in patients with acute myocardial infarction may provide
      limitation infarct size and improvement in left ventricular volumes and function in acute and
      late phases (6 months).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2007</start_date>
  <completion_date type="Actual">February 2008</completion_date>
  <primary_completion_date type="Actual">January 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Left ventricular infarct size by SPECT</measure>
    <time_frame>at long term (5-6 months)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Left ventricular diastolic volume</measure>
    <time_frame>at long term (5-6 months)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Left ventricular systolic volume</measure>
    <time_frame>at long term (5-6 months)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Left ventricular ejection fraction</measure>
    <time_frame>at long term (5-6 months)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Temporal changes (from baseline to 5 months follow-up) in microvascular perfusion indices (index of microvascular resistance, coronary flow reserve) and in infarct size have been interrogated in only control group.</measure>
    <time_frame>early phase (at discharge) and late phase (5-6 months)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reinfarction</measure>
    <time_frame>from recruitment until the last follow-up at 5-6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major bleeding</measure>
    <time_frame>from recruitment to discharge</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">53</enrollment>
  <condition>Acute Coronary Syndromes</condition>
  <condition>Acute Myocardial Infarction</condition>
  <condition>Reperfusion Injury</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Following standard primary percutaneous coronary intervention for ST elevation acute myocardial infarction 250.000 U intracoronary Streptokinase will be given</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard percutaneous coronary intervention for ST elevation myocardial infarction will be performed</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Streptokinase</intervention_name>
    <description>intracoronary infusion, 250.000 Units</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Streptase (Streptokinase)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>primary percutaneous coronary intervention</intervention_name>
    <description>balloon catheter, stent</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Continuous chest pain that lasted &gt; 30 minutes within the preceding 12 hours

          -  ST-segment elevation of at least 1 mm in 2 contiguous leads on the ECG

          -  Infarct related artery (IRA) occlusion (TIMI grade 0) at the angiography

        Exclusion Criteria:

          -  Contraindications to streptokinase, tirofiban, aspirin, clopidogrel, or heparin

          -  Culprit lesion in saphenous vein graft

          -  TIMI grade II-III flow in IRA

          -  Additional epicardial stenosis in the IRA distal to stented segment (significant or
             insignificant)

          -  Presence of left bundle branch block

          -  History of prior MI
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Murat Sezer, Assoc. Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Istanbul University, Istanbul Faculty of Medicine, Department of Cardiology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sabahattin Umman, Prof.</last_name>
    <role>Study Director</role>
    <affiliation>Istanbul University,Istanbul Faculty of Medicine, Department of Cardiology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Arif O Cimen, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Istanbul University, Istanbul Faculty of Medicine, Department of Cardiology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Emre K Aslanger, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Istanbul University, Istanbul Faculty of Medicine, Department of Cardiology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Berrin Umman, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Istanbul University, Istanbul Faculty of Medicine, Department of Cardiology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Zehra Bugra, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Istanbul University, Istanbul Faculty of Medicine, Department of Cardiology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Isik Adalet, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Istanbul University, Istanbul Faculty of Medicine, Department of Nuclear Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cuneyt Turkmen, Assoc. Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Istanbul University, Istanbul Faculty of Medicine, Department of Nuclear Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Istanbul University, Istanbul Faculty of Medicine, Department of Cardiology</name>
      <address>
        <city>Istanbul</city>
        <zip>34290</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Sezer M, Oflaz H, Gören T, Okçular I, Umman B, Nişanci Y, Bilge AK, Sanli Y, Meriç M, Umman S. Intracoronary streptokinase after primary percutaneous coronary intervention. N Engl J Med. 2007 May 3;356(18):1823-34.</citation>
    <PMID>17476008</PMID>
  </reference>
  <verification_date>June 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 22, 2008</study_first_submitted>
  <study_first_submitted_qc>February 22, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 3, 2008</study_first_posted>
  <last_update_submitted>June 22, 2009</last_update_submitted>
  <last_update_submitted_qc>June 22, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 23, 2009</last_update_posted>
  <responsible_party>
    <name_title>Istanbul University</name_title>
    <organization>Istanbul University, Istanbul Faculty of Medicine, Department of Cardiology</organization>
  </responsible_party>
  <keyword>coronary microcirculation</keyword>
  <keyword>acut myocardial infarction</keyword>
  <keyword>infarct size</keyword>
  <keyword>streptokinase</keyword>
  <keyword>reperfusion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>Reperfusion Injury</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Streptokinase</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

